| Type | Title | Date Released | |
|---|---|---|---|
425 | Form 425 | ||
424B3 | UPDATE TO PRIOR PROSPECTUS | Shares: 3,245,595 | ||
10-Q | Form 10-Q | ||
8-K | Medicus Pharma Announces Proposed SkinJect® Business Combination and Concurrent Financing | ||
425 | Form 425 | ||
DEF 14A | Form DEF 14A | ||
424B3 | UPDATE TO PRIOR PROSPECTUS | Shares: 64,911 | ||
8-K | Nasdaq Confirms Compliance Restored After Company’s Shares Reclaim $1 Minimum Bid Price Requirement | ||
PRE 14A | Form PRE 14A | ||
424B3 | Form 424B3 | ||
8-K | Medicus Pharma Ltd. Announces 1-for-50 Share Consolidation | ||
SCHEDULE 13G/A | Melani Kenneth R. (Filed by) |
